chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: FLUC4
Symptoms: Erythema, Rash papular
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723309), concerns a 52-year-old, adult, female patient. On 18-Oct-2017, the patient was administered FLUCELVAX QIV [dose: 0.5 ml (frequency: 1), route of administration: intramuscular, anatomical location: right arm, batch number; 195225A and expiry date: not reported]. On 23-Oct-2017, 5 days after vaccination, the patient experienced small raised bumps on the top of both arm which was spreading to neck, and mild redness. It was reported that the patient had no itching. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious. Update 29-Aug-2018: Significant case correction performed with IRD 16-Aug-2018: The listedness for the event, injection site rash was changed from unlisted to listed for documents and the listedness for the event erythema was changed from unlisted to listed for document. The event verbatim was modified from 'small raised bumps on the top of both arms' to 'small raised bumps'.
Age: 55.0
Sex: F
Vaccine: FLUC4
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723338), concerns a 55-year-old, adult female patient. The patient had no historical conditions and current illness. The patient had been allergic to ROBINUL. The patient's concomitant medications included VYVANSE and CELEXA for unknown indications. On 14-Oct-2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 195228, expiry date: not reported). On the same day, after vaccination, the patient experienced pain with lifting arm overhead and reaching out to pick up something. It was reported that, the pain reached across the body caused the joint pain. The patient had done gentle stretching. On 27-Oct-2017, the patient started to take ADVIL. No lab investigations were performed. At the time of report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious. Update on 29-AUG-2018: Non-significant case correction was performed with IRD 16-AUG-2018. The spelling mistake in the case comment was corrected.
Age: 12.0
Sex: M
Vaccine: FLUC4
Symptoms: Loss of consciousness
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723350), concerns a 12-year-old, adolescent, male patient. The patient had passed out in the past. Patient did not have any allergies and current illnesses. Patient did not take any medications at the time of vaccination. On 28-Oct-2017, the patient was administered FLUCELVAX QIV [route of administration: intramuscular, dose: 0.5 ml (frequency reported as 1), anatomical location: left arm, batch number: 195230 and expiry date: not reported]. On the same day, after vaccination, within approximately 5 minutes, the patient passed out while standing next to his mother. The reporter was notified and immediately patient was rendered aid. The patient was unconscious upon the reporter's arrival, though he opened his eye by the time reporter knelt on the floor. Patient's parents stated he had not eaten much more than popcorn all day and had passed out one other time similar to this episode. Patient stayed sitting for approximately 20 minutes before the parents continued with their day. Upon departure the patient and his parents seemed fine. They were instructed by the reporter to follow up with a healthcare provider if any other signs or symptoms developed. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 21.0
Sex: F
Vaccine: FLUC4
Symptoms: Arthralgia, Pain, Product administered at inappropriate site
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723360) concerning a 21-year-old, adult, female patient. The patient had no historical condition and allergy. The patient's current illness included cold (since and unspecified date in Sep-2017) (reported as around 19-Sep-2017). The patient's concomitant medications included OCELLA for birth control and citalopram for an unknown indication. On 14-Oct-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 195228 and expiry date: not reported]. It was reported that, the vaccine was administered too high (explicitly coded as vaccine administered at inappropriate site). On the same day, after vaccination, the patient developed pain and joint pain in shoulder, when she lifted her arm behind her back and over shoulder level. No lab investigations were performed. At the time of the report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 50.0
Sex: M
Vaccine: FLUC4
Symptoms: Injected limb mobility decreased, Injection site pain, Pain, Tension
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723384), concerns a 50-year-old, adult, male patient. The patient had no known drug allergy (NKDA) and no current illnesses. The patient did not receive any concomitant medications. On 21-Oct-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml (frequency reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 195240A and expiry date not reported]. During administration of the vaccine, the patient was tensed up and was told to relax. On 23-Oct-2017, 2 days after vaccination, patient complained of sore arm from injection site. The pain radiated from shoulder down to arm, which made him unable to function with his left arm. The patient had made a physician office visit. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious. Update 29-Aug-2018: Non-significant case correction was performed 16-Aug-2018: The case comment was amended.
Age: 70.0
Sex: F
Vaccine: FLUC4
Symptoms: Syncope
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723774), concerns a 70-year-old, elderly, female patient. The patient's historical condition included fainting (on an unspecified date). The patient was allergic to berries and penicillin. On 30-Oct-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, frequency: 1, route of administration: intramuscular, anatomical location: left arm, batch number: 195124 and expiry date: not reported]. On the same day, after vaccination, the patient fainted. On an unspecified date, the patient had an emergency room and office visit. At the time of this report, the outcome of the event was unknown. The reporter assessed this case as non-serious.
Age: 47.0
Sex: F
Vaccine: FLUC4
Symptoms: Nasopharyngitis, Pruritus, Rash, Rash erythematous
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723926), concerns a 47-year-old, adult female patient, The patient had a flu shot around 13 years ago and had not experienced any adverse reactions. The patient's current conditions included type 2 diabetes, hypertension, hyperlipidaemia, hypothyroidism and acute otitis media left ear (since Sep-2017). The patient was allergic to codeine, meperidine and opioid class. Patient did not have allergies to neomycin, eggs or latex. The patient's concomitant medications included JANUVIA, Ferrous sulfate, simvastatin, levothyroxine, glipizide, ibuprofen, amlodipine and losartan for unknown indications. On 27-Oct-2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, frequency reported as 1, route of administration: intramuscular, anatomical location: left arm, batch number: 195215 and expiry date: not reported). On 28-Oct-2017, one day after vaccination, the patient developed red bumps on her chest, that wasn't itchy. On 30-Oct-2017 (reported as today), the patient stated that she developed more red bumps or rash on stomach and on her arms (crease of elbow). Patient had itchy areas (severity: mild) only on her chest. The patient had no injection site pain or rash. The patient had not taken any new medications or foods or used any new soaps or detergents. On an unspecified date in Oct-2017, the patient had cold like symptoms that she attributed to the shot and had not gotten it since. The reporter recommended the patient topo visit her primary care provider the next day and recommended her to take antihistamine like BENADRYL or CLARITIN if itchiness worsened. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 11.0
Sex: F
Vaccine: FLUC4
Symptoms: Eye movement disorder, Hunger, Loss of consciousness, Posture abnormal, Sensory loss
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 723966), concerns a 11-year-old, female child patient. On 28-Oct-2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml (frequency reported as 1), route of administration: intramuscular, batch number: 195528 (as reported) anatomical location: unknown and expiry date: not reported). The reported batch number (195528) was matching to batch numbers (195128 and 195228). Hence, query regarding the batch number has been raised to quality assurance. On the same day, after vaccination, the patient passed out for about 3 to 5 seconds and her head and eyes rolled back. The patient dropped the phone on which she was watching a video (reported as watching a video on came back up). It was reported that, the patient was hungry and 'could not feel body'. The reporter gave the patient orange juice after which the patient was fine. The same day (28-Oct-2017), the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 57.0
Sex: M
Vaccine: FLUC4
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 724033), concerns a 57-year-old, adult, male patient. On 01-Oct-2017, the patient was administered FLUCELVAX (QIVc) [dose: 0.5 ml, route of administration, anatomical location, batch number, expiry date: not reported]. On the same day (01-Oct-2017), after vaccination, the patient experienced sore arm. At the time of this report, the outcome of the event was not reported. The reporter assessed this case as non-serious.
Age: 47.0
Sex: F
Vaccine: FLUC4
Symptoms: Asthenia, Diplopia, Disturbance in attention, Dizziness, Feeling abnormal
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 724111), concerns a 47-year-old, adult, female patient. Patient's historical condition included Glucose-6-phosphate dehydrogenase (G6PD) deficiency and was allergic to penicillin, sulfa-based drugs and SEPTOCAINE. Patient did not have any current conditions. The patient was not taking any concomitant medications at the time of vaccination. On 30-oct-2017, the patient was administered FLUCELVAX QIVc [route of administration: injection (reported as SYR), anatomical location: left arm, dose: 0.5 ml (frequency reported as 1), batch number: 195128 (reported as L195128) and expiry date not reported]. On the same day, immediately after vaccination, the patient felt a little spacey which increased over the afternoon at work (was not able to focus well mentally). Early evening, when the patient went to bed she became very dizzy when she turned her head. Later in the night, patient woke up with vertigo (visual spinning) and double vision, with some mild nausea. Patient was a little dizzy the rest of the night. Next morning, she was spacey again, couldn't focus on her work and was a little dizzy. Patient had mild nausea and felt weak when she was standing. Patient was resting at home the rest of the day and hoped that she would feel better without any medical treatment. Patient did not undergo any laboratory tests. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 47.0
Sex: F
Vaccine: FLUC4
Symptoms: Immediate post-injection reaction, Nausea, Vertigo
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 724111), concerns a 47-year-old, adult, female patient. Patient's historical condition included Glucose-6-phosphate dehydrogenase (G6PD) deficiency and was allergic to penicillin, sulfa-based drugs and SEPTOCAINE. Patient did not have any current conditions. The patient was not taking any concomitant medications at the time of vaccination. On 30-oct-2017, the patient was administered FLUCELVAX QIVc [route of administration: injection (reported as SYR), anatomical location: left arm, dose: 0.5 ml (frequency reported as 1), batch number: 195128 (reported as L195128) and expiry date not reported]. On the same day, immediately after vaccination, the patient felt a little spacey which increased over the afternoon at work (was not able to focus well mentally). Early evening, when the patient went to bed she became very dizzy when she turned her head. Later in the night, patient woke up with vertigo (visual spinning) and double vision, with some mild nausea. Patient was a little dizzy the rest of the night. Next morning, she was spacey again, couldn't focus on her work and was a little dizzy. Patient had mild nausea and felt weak when she was standing. Patient was resting at home the rest of the day and hoped that she would feel better without any medical treatment. Patient did not undergo any laboratory tests. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 52.0
Sex: F
Vaccine: FLUC4
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 16-Aug-2018 by Seqirus from VAERS (VAERS ID: 724153), concerns a 52-year-old adult female patient. The patient had no allergies. On 25-Oct-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml (frequency reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number; 195212 and expiry date: not reported]. On 26-Oct-2017, 01 day after vaccination, the patient developed swollen and painful lymph nodes on her left neck and collarbone area. It was reported that, no treatment was needed or rendered. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 8.0
Sex: F
Vaccine: FLUC4
Symptoms: Dyskinesia, Fall, Skin abrasion, Swelling face, Syncope
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 724320), concerns a 08-year-old, child, female patient. On 30-Oct-2017, the patient was administered FLUCELVAX (QIVc) [dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 195245, expiry date: not reported]. On the same day, after administration of the vaccine, the patient and her mother left the room. The patient fainted and experienced jerky movements of the extremities lasting 10-15 seconds in the hallway. The nurse did not see when the patient fainted, but it was witnessed by another mother present for her child to get the flu vaccine. The witness happened to be a registered nurse and reported the jerky movements. The patient awoke after 15 seconds and was able to say her name and location correctly. The patient had scrape on her forehead and was lying with her head against a brick wall. The patient was unsure whether the scrape was due to the fall or jerky movement. The patient was taken to hospital by her mother. Upon follow up to the patient's mother, it was confirmed by the doctor, that everything was normal but had referred to neurologist just to rule out any complication. The patient's mother further reported that the patient attended school the next day and indicated that the patient just had sensitivity to touch where she had a "goose egg" on her forehead. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 8.0
Sex: F
Vaccine: FLUC4
Symptoms: Tenderness
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 724320), concerns a 08-year-old, child, female patient. On 30-Oct-2017, the patient was administered FLUCELVAX (QIVc) [dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 195245, expiry date: not reported]. On the same day, after administration of the vaccine, the patient and her mother left the room. The patient fainted and experienced jerky movements of the extremities lasting 10-15 seconds in the hallway. The nurse did not see when the patient fainted, but it was witnessed by another mother present for her child to get the flu vaccine. The witness happened to be a registered nurse and reported the jerky movements. The patient awoke after 15 seconds and was able to say her name and location correctly. The patient had scrape on her forehead and was lying with her head against a brick wall. The patient was unsure whether the scrape was due to the fall or jerky movement. The patient was taken to hospital by her mother. Upon follow up to the patient's mother, it was confirmed by the doctor, that everything was normal but had referred to neurologist just to rule out any complication. The patient's mother further reported that the patient attended school the next day and indicated that the patient just had sensitivity to touch where she had a "goose egg" on her forehead. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 21.0
Sex: M
Vaccine: FLUC4, IPV, MMR
Symptoms: Dyskinesia, Loss of consciousness, Posture abnormal, Syncope
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 725571), concerns a 21-year-old, adult, male patient. The patient's historical condition, current illness and allergies were not reported. The patient's concomitant medications were unknown. On 05-Nov-2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, batch number: 195247, route of administration, anatomical location: unknown and expiry date: not reported) and non-company suspect vaccines MMR II (batch number: N009799, dose, route of administration, anatomical location: unknown and expiry date: not reported) and IPOL (batch number: N1J451M, dose, route of administration, anatomical location: unknown and expiry date: not reported). On the same day, after vaccination with MMR, polio and influenza vaccines, the patient fainted and experienced jerking of upper extremity and her lower extremities were drawn to chest. The patient experienced loss of consciousness for approximately 10-15 seconds. Unspecified period after the prior mentioned events, the patient was alert and oriented (to person, place and time) (reported as A/Ox3). The patient did not report any residual problems and symptoms. At the time of this report, the patient had recovered from all the events. The reporter assessed this case as non-serious.
Age: 10.0
Sex: F
Vaccine: FLUC4
Symptoms: Cough, Dizziness, Fatigue, Hypoacusis, Syncope
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 725981), concerns a 10-year-old, female child. The patient had no relevant medical history, concomitant medication, current illness and allergies. On 09-Nov-2017, the patient was administered FLUCELVAX (QIVc) [dose: 0.5 ml, route of administration, anatomical location, batch number, expiry date: not reported]. On the same day, within a couple of minutes after vaccination, the patient reported that, she could not hear, felt very tired and was about to faint. Eventually, the patient collapsed and knelt on the floor and held the legs of the reporter for support. The patient began to cough and vomited a small amount. The patient complained again that she felt like she was about to pass out. About 15 minutes later, the patient recovered sufficiently and walked to the car and they drove home. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 10.0
Sex: F
Vaccine: FLUC4
Symptoms: Vomiting
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 725981), concerns a 10-year-old, female child. The patient had no relevant medical history, concomitant medication, current illness and allergies. On 09-Nov-2017, the patient was administered FLUCELVAX (QIVc) [dose: 0.5 ml, route of administration, anatomical location, batch number, expiry date: not reported]. On the same day, within a couple of minutes after vaccination, the patient reported that, she could not hear, felt very tired and was about to faint. Eventually, the patient collapsed and knelt on the floor and held the legs of the reporter for support. The patient began to cough and vomited a small amount. The patient complained again that she felt like she was about to pass out. About 15 minutes later, the patient recovered sufficiently and walked to the car and they drove home. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 5.0
Sex: F
Vaccine: FLUC4
Symptoms: Injection site swelling, Joint range of motion decreased, Oedema, Peripheral swelling, Skin warm
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 726699), concerns a 05-year-old, female child. The patient did not have any known allergy or known drug allergy. On 02-Nov-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 195231 and expiry date not reported]. On the same day evening, after vaccination, the patient began to develop edema. Next morning, Patient's mother noticed that the edema became worse and got bigger. The patient had severe swelling about 13 cm in length, starting 2 inches above elbow proceeding over bicep in shoulder. The swollen tissue was warm to touch and tender. On the same day the patient was brought to the clinic by the mother for right arm swelling. The mother stated that no medications were given. The patient also had decreased range of motion. The physician (MD) evaluated the patient and a border was marked near the elbow. The patient's mother was instructed that if swelling proceeded post marked border near the elbow. The patient's mother was instructed that if swelling proceeded post marked border she had to bring her daughter back into clinic. At the time of this report, it was unknown if the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 5.0
Sex: F
Vaccine: FLUC4
Symptoms: Tenderness
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 726699), concerns a 05-year-old, female child. The patient did not have any known allergy or known drug allergy. On 02-Nov-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 195231 and expiry date not reported]. On the same day evening, after vaccination, the patient began to develop edema. Next morning, Patient's mother noticed that the edema became worse and got bigger. The patient had severe swelling about 13 cm in length, starting 2 inches above elbow proceeding over bicep in shoulder. The swollen tissue was warm to touch and tender. On the same day the patient was brought to the clinic by the mother for right arm swelling. The mother stated that no medications were given. The patient also had decreased range of motion. The physician (MD) evaluated the patient and a border was marked near the elbow. The patient's mother was instructed that if swelling proceeded post marked border near the elbow. The patient's mother was instructed that if swelling proceeded post marked border she had to bring her daughter back into clinic. At the time of this report, it was unknown if the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 27.0
Sex: M
Vaccine: FLUC4
Symptoms: Loss of consciousness
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 727003), concerning a 27-year-old, adult, male patient. On 03-Nov-2017, the patient was administered FLUCELVAX (QIVc) (dose: 0.5 ml, batch number: 195124, route of administration: intramuscular, anatomical location: right arm and expiry date: not reported). On the same day after the vaccination, the patient had passed out for a couple of seconds. The patient was sitting on a chair and did not sustain any further injury. Later, the patient was evaluated by the provider and was cleared to leave the clinic. At the time of the report, the patient had recovered from the event. The reported assessed the case as non-serious.
Age: 26.0
Sex: F
Vaccine: FLUC4
Symptoms: Headache, Oropharyngeal pain, Urticaria
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 727012), concerns a 26-year-old, adult female patient. The patient's historical condition included purified protein derivative (PPD) converter (as reported). The patient's current condition included sinus/head cold. The patient had no known allergies and did not received any concomitant medication. On 08-Nov-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: injection (reported as SYR), anatomical location: left arm, batch number and expiry date: not reported]. On 10-Nov-2017, 2 days after vaccination, the patient experienced sore throat, hives which started on wrists and hands but progressed up to arms, feet and top of thighs. In addition, the patient also experienced headache. The patient had no breathing impacts other than sore throat. On an unspecified date, the patient had recovered from the events. The reporter assessed the case as non-serious. Update received on 27-Sep-2018: Significant case correction (IRD: 26-Aug-2018): The historical condition (PPD skin test) was added in the patient tab. No changes were done in the narrative.
Age: 45.0
Sex: M
Vaccine: FLUC4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 727201), concerns a 45-year-old, adult male patient. The patient received an influenza vaccine (flu shot) 3 weeks prior (according to a different family member). The patient's current indication included mental disability (reported as historical condition). The concomitant medication was unknown. On 16-Nov-2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, frequency reported as unknown, route of administration, anatomical location, batch number and expiry date: not reported). As the patient received a flu shot 3 weeks prior to the current vaccination. The patient did not experience any adverse event. The reporter assessed the case as non-serious.
Age: 14.0
Sex: F
Vaccine: FLUC4, HPV9
Symptoms: Loss of consciousness
Clinical narrative: This  is spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 727359), concerns a 14-year-old, female adolescent patient. The patient had no historical condition, current illness and allergies. The patient did not receive any concomitant medications. On 19-May-2017, the patient received HPV and blacked out. On 17-Nov-2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 195231, expiry date: not reported). and non-company suspect product GARDASIL 9 (dose: frequency reported as 3, route of administration: intramuscular, anatomical location: right arm, batch number: N010497, expiry date: not reported). On the same day, after vaccinations, patient's parents were instructed to stay for 15 minutes by medical assistant [MA], but patient did not stay back for 15 minutes. The patient was with her parents in clinic parking lot, where she blacked out. Eventually, the patient was placed in a wheel chair and escorted back into the chair. The staff members informed that, the patient did not eat or drink anything all day. At the time of this report, the patient had recovered from the event. The reporter assessed the case as non-serious.
Age: 28.0
Sex: M
Vaccine: FLUC4
Symptoms: Loss of consciousness, Syncope
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 727393), concerns a 28-year-old, adult male patient. The patient's historical condition and current illness were unknown. The patient had no allergies. On 17-Nov-2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 195226, expiry date: not reported). On the same day, 2 minutes after vaccination, the patient fainted and had loss of consciousness. The patient was administered EPIPEN and after that patient regained consciousness. It was reported that, an emergency medical technician [EMT] arrived and took the patient to the emergency room [ER]. At the time of this report, the patient had recovered from the event. The reporter assessed the case as non-serious.
Age: 10.0
Sex: F
Vaccine: FLUC4
Symptoms: Blood thyroid stimulating hormone normal, Differential white blood cell count normal, Dizziness, Full blood count normal, Loss of consciousness
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERs (VAERS ID: 727596), concerns a 10-year-old, female child patient. The patient had no historical condition, current illness and allergies. The patient did not receive any concomitant medications. On 21-Oct-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml (frequency reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 195219, expiry date: not reported]. On the same day, after vaccination, the patient experienced dizziness and syncope. The patient also experienced loss of consciousness for about 5 seconds. The patient had made a physician office visit. On an unspecified date in Oct-2017, 4 days after the incident of syncope, the patient underwent complete blood count (CBC), differential white blood cell count, comprehensive metabolic panel (CMP), thyroid-stimulating hormone (TSH) and erythrocyte sedimentation rate (ESR) tests and all were found to be normal (negative). At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 10.0
Sex: F
Vaccine: FLUC4
Symptoms: Metabolic function test normal, Red blood cell sedimentation rate normal, Syncope
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERs (VAERS ID: 727596), concerns a 10-year-old, female child patient. The patient had no historical condition, current illness and allergies. The patient did not receive any concomitant medications. On 21-Oct-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml (frequency reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 195219, expiry date: not reported]. On the same day, after vaccination, the patient experienced dizziness and syncope. The patient also experienced loss of consciousness for about 5 seconds. The patient had made a physician office visit. On an unspecified date in Oct-2017, 4 days after the incident of syncope, the patient underwent complete blood count (CBC), differential white blood cell count, comprehensive metabolic panel (CMP), thyroid-stimulating hormone (TSH) and erythrocyte sedimentation rate (ESR) tests and all were found to be normal (negative). At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 34.0
Sex: M
Vaccine: FLUC4
Symptoms: Syncope
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 727622), concerns a 34-year-old, adult, male patient. The patient had no historical condition (reported as no known chronic conditions), no known allergies. The patient's current illness included possible cold. The patient's concomitant medication included Multivitamin for an unknown indication. On 16-Nov-2017, the patient was administered FLUCELVAX (QIVc) [dose: 0.5 ml (frequency reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: 195222, expiry date: not reported]. On the same day, after vaccination, the patient experienced syncope which lasted for seconds. The patient was evaluated by paramedics and advised the patient to contact the primary provider. The patient had an appointment with primary provider on 21-Nov-2017. At the time of this report, the outcome of the event was unknown. The reporter assessed this case as non-serious.
Age: 23.0
Sex: M
Vaccine: FLUC4
Symptoms: Back pain, Chills, Dizziness, Hyperhidrosis, Loss of consciousness
Clinical narrative: This is a spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 728256) and concerns a 23-year old, adult male patient. The patient had no relevant medical history and current illness. The patient was allergic to penicillin and ibuprofen (since an unspecified date). The patient's concomitant medication included SELRX. On 25-Nov-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml [frequency: 1 as reported], route of administration: intramuscular, anatomical location: left arm, batch number: 195228 and expiry date not reported]. On the same day, about 20 minutes after vaccination, the patient felt lightheadedness and an hour later, the patient experienced chills, backaches. The patient vomited 5-6 times and had profuse sweating. Then the patient blacked out for a few seconds (recovered) and fell asleep for hours. It was reported that, the patient tried to eat but vomited back. Since then he did not eat anything. On an unspecified date, the patient had a physician office visit. At the time of this report, the outcome of the events (felt lightheaded, chills, backaches, vomited, profuse sweating) was unknown. The reporter assessed this case as non-serious.
Age: 23.0
Sex: M
Vaccine: FLUC4
Symptoms: Somnolence, Vomiting
Clinical narrative: This is a spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 728256) and concerns a 23-year old, adult male patient. The patient had no relevant medical history and current illness. The patient was allergic to penicillin and ibuprofen (since an unspecified date). The patient's concomitant medication included SELRX. On 25-Nov-2017, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml [frequency: 1 as reported], route of administration: intramuscular, anatomical location: left arm, batch number: 195228 and expiry date not reported]. On the same day, about 20 minutes after vaccination, the patient felt lightheadedness and an hour later, the patient experienced chills, backaches. The patient vomited 5-6 times and had profuse sweating. Then the patient blacked out for a few seconds (recovered) and fell asleep for hours. It was reported that, the patient tried to eat but vomited back. Since then he did not eat anything. On an unspecified date, the patient had a physician office visit. At the time of this report, the outcome of the events (felt lightheaded, chills, backaches, vomited, profuse sweating) was unknown. The reporter assessed this case as non-serious.
Age: 8.0
Sex: M
Vaccine: FLUC4
Symptoms: Anxiety, Fall, Syncope, Tension, Vomiting
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 728263), concerns an 8-year-old, child, male patient. The patient's medical history and concomitant medications were unknown. On 26-Nov-2017, the patient was anxious about the flu shot. The patient's mother and healthcare professional tried to comfort the child and told that the vaccine would prevent flu. On 26-Nov-2017, the patient was administered FLUCELVAX (QIVc) [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 195233, expiry date: not reported]. On the same day of vaccination, the patient was still and tensed during injection and complained that it was bad. The patient stood next to his mother, so that his father could get his vaccine. The patient talked with his parents and the healthcare professional during the vaccination of patient's father and eventually the family were ready to leave. The patient fainted and fell on the floor eventually. The patient fell on the healthcare professional before he could hit the ground. The patient's mother rose him from the ground and called 911. The patient woke up after about 10-15 seconds. The patient continued to lie on the ground and nodded in response to his mother. The patient asked for water and wanted to sit up. The patient's father got water and his mother assisted the patient onto chair. The patient gave short answers to questions and had some water. Eventually, the Emergency medical technician (EMT's) arrived and spoke with parents about vasovagal reaction and the patient vomited. The patient's parents subsequently decided to let the ambulance take the patient to the hospital and have him examined by a physician. The outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 33.0
Sex: M
Vaccine: FLUC4, TDAP
Symptoms: Syncope, Urinary incontinence
Clinical narrative: This spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERS ID: 728305), concerns a 33-year-old, adult, male patient. On 13-Nov-2017, the patient was administered FLUCELVAX QIVc [route of administration: intramuscular, anatomical location: right arm, dose: 0.5 ml (frequency reported as 1), batch number: 195238 and expiry date not reported]. Patient was also administered BOOSTRIX, route of administration: intramuscular, anatomical location: left arm, dose: reported as 1, batch number: TB2R2 and expiry date: not reported]. On the same day after vaccination, patient experienced syncope with urinary incontinence when passed out during first episode. It was reported that patient fainted twice. Ambulance was called. The patient was treated by emergency medical technician and was transported to hospital. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 12.0
Sex: F
Vaccine: FLUC4
Symptoms: Back injury, Fall, Head injury, Syncope
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 26-Aug-2018 by Seqirus from VAERS (VAERs ID: 728640), concerns a 12-year-old, female adolescent patient. On 28-Nov-2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 195228, expiry date: not reported). On the same day, after vaccination, the patient fainted twice and fell on end cap in the store and hit her head and back eventually. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 40.0
Sex: F
Vaccine: FLUC4
Symptoms: Dysphonia, Fatigue, Swelling of eyelid
Clinical narrative: This spontaneous case, reported by non-health care professional (other) to VAERS and initially retrieved on 14-Mar-2018 by Seqirus from VAERS (VAERS ID: 728958), concerns a 40-year-old, adult, female patient. The patient's historical condition included tinnitus and allergic rhinitis (on unspecified dates). The patient was also allergic to latex, amoxicillin, penicillin and TYLENOL. The patient never had any nasal reaction in the past. The concomitant medications were not reported. It was reported that, over 5 years ago the patient received an unknown injection. On 30-Nov-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 195250 and expiry date: not reported). On the same day, around 10 PM, the patient experienced unexplained hoarseness, puffy eyes and fatigue. The next morning (01-Dec-17) at around 04:25 AM, the patient woke up with swollen right eye, mainly underneath the eye. It was reported that, the patient was fatigue, which was never the normal reaction of her body functions. At the time of this report, the patient had not recovered from the events (eyelid oedema, hoarseness and fatigue). The reporter assessed this case as non-serious. Non-significant case correction received 14-Mar-2018: Case comment was amended.
Age: 54.0
Sex: F
Vaccine: FLUC4, TDAP
Symptoms: Contusion, Hypoaesthesia, Pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 14-Mar-2018 by Seqirus from VAERS (VAERS ID: 728983), concerning a 54-year-old, adult female patient. The patient's medical history and concomitant medications were not reported. On 04-Nov-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 195231, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug ADACEL (route of administration: intramuscular, anatomical location: right arm, batch number: 65262AD, dose and expiry date: not reported). On 05-Nov-2017, after 1 day of vaccination, the patient had extremely sore pain and numbness for 3 days. As of 19-Nov-2017, the patient experienced bruise. As of 1-Dec-2017, the patient experienced constant ache, with numbness down to forefinger and in thumb area. It was reported that, the lower grade ache and numbness was stabilized. The patient had to visit emergency room for the events. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious. Non-significant case correction received with IRD 14-Mar-2018: Narrative was corrected accordingly.
Age: 36.0
Sex: M
Vaccine: FLUC4
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 14-Mar-2018 by Seqirus from VAERS (VAERS ID: 729026), concerns a 36-year-old, adult, male patient. It was reported that, the patient experienced rash and hives with AUGMENTIN. The patient had no current condition and concomitant medications. On 22-Nov-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). On 30-Nov-2017, after 9 days of vaccination, the patient experienced sore in whole arm which was progressively worse. The patient also experienced tingling and numbness in fingers. It was reported that, no lab tests were done to the patient. At the time of the report, the outcome of the events (tingling, numbness in fingers and pain in extremity) was not reported. The reporter assessed this case as non-serious.
Age: 14.0
Sex: M
Vaccine: FLUC4
Symptoms: Muscular weakness, Myalgia, Paraesthesia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 14-Mar-2018 by Seqirus from VAERS (VAERS ID: 729027), concerns a 14-year-old, adolescent male patient. The patient had no relevant medical history, allergies or current conditions. On 24-Nov-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported). On 27-Nov-2017, after 3 days of vaccination, the patient had myalgia, muscle weakness and tingling in hands and feet. On an unspecified date, the patient had consulted physician. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUC4
Symptoms: Injected limb mobility decreased
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 14-Mar-2018 by Seqirus from VAERS (VAERS ID: 729044), concerns a 38-year-old adult female patient. On 19-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: injection (SYR), anatomical location: left arm, expiry date: not reported). On an unspecified date, after the administration of vaccine, the patient's mobility of the arm was decreased, which resulting in a need for the doctor visit and physician therapy. The outcome of the event was not recovered. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 14-Mar-2018: Case comment was corrected accordingly.
Age: 52.0
Sex: F
Vaccine: FLUC4
Symptoms: Injection site bruising, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: This is a spontaneous case, reported by other health professional to VAERS and initially retrieved on 14-Mar-2018 by Seqirus from VAERS (VAERS ID: 729071), concerning a 52-year-old, adult female patient. It was reported that, the patient had no reactions to any previous flu vaccines. The patient's medical history and concomitant medication was not reported. On 26-Sep-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 195215, expiry date: not reported). On the same day, after vaccination, the patient had two raised, red spots slightly below the injection site. The patient was advised to ice it and take BENADRYL that night. Reported that, the two spots had combined into one bigger one. The patient had no discomfort, but it was a little itchy. It was reported that, the patient had not applied ice nor taken BENADRYL the night before. However, the spot became less red and less raised, with no discomfort and no itching. The patient was advised to visit her primary care provider if it was necessary. The outcome of the events injection site erythema, injection site pruritus, injection site bruising and injection site swelling were unknown. The reporter assessed the events as non-serious.